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ABSTRACT
The objectives of this work are the isolation, purification, structure elucidation,
and biological evaluation of bioactive secondary metabolites, primarily tannins and
diterpenoids, of two plant species: silver maple (Acer saccharinum) and Euphorbia
saudiarabica, respectively.
Based on the ethnopharmacological literature, Acer saccharinum is a traditional
medicinal plant that has been used by the people of North America. According to
previous phytopharmacological studies by our group, over 70 phytochemicals, primarily
tannins and flavonoids, have been discovered from three different maple species,
including sugar (Acer saccharum), red (Acer rubrum), and sycamore (Acer
pseudoplatanus) maples. Remarkably, the red maple species yielded very interesting
bioactive (α-glucosidase inhibitors) glucitol-core containing gallotannins (GCGs).
Therefore, to gain a better understanding of the phytochemical composition of other
maple species, such as silver maple, the fresh leaves of silver maple were collected and
extracted. Following this, the crude extracts of different polarities were prepared, and
then all extracts initially screened using reversed-phase high-performance liquid
chromatography (RP-HPLC) and thin-layer chromatography (TLC), and the FolinCiocalteau assay for quantifying polyphenol contents. Then, the isolation procedure was
carried out using multiple techniques, including open column chromatography (OCC),
TLC, and RP-HPLC on the highest total polyphenol content extract (which was the ethyl
acetate [EtOAc] extract). Using high-performance liquid chromatography with diodearray detector (HPLC-DAD) analyses using previously isolated standards, nine
compounds, including six GCGs, were identified as ginnalins A–C (1–3), maplexins B,

D, and F (4–6), methyl syringate (7), methyl gallate (8), and 3-methoxy-4hydroxyphenol-1-β-D-(6-galloyl)-glucopyranoside (9). Additionally, pubineroid A
(10), a sesquiterpenoid, was isolated and identified (by NMR).
The Euphorbia genus is one of the six largest genera of flowering plants which
are known to produce several bioactive secondary metabolites, primarily diterpenes
such as jatrophane and lathyrane-type. Euphorbia saudiarabica, which is endemic to
Saudi Arabia, is well characterized by the production of a milky irritant latex. It is one
of the plant species in the region that has not been studied. To increase the knowledge
of the constituents of E. saudiarabica, a comprehensive phytochemical investigation
was conducted, leading to the isolation of five new lathyrane-type diterpenoids (1-5)
named saudiarabicain A–E. These compounds were evaluated for their cytotoxic
activities against three cell lines, including, murine B16F10 melanoma cells, human
HaCat keratinocytes, and human SH-SY5Y neuroblastoma cells. In B16F10 melanoma
cells, only compounds 2, 3, and 4 induced significant toxicity, with compound 2 having
the greatest range of toxicity from 100 μM (49.63% decrease) to 20 μM (14.69%
decrease). In human keratinocytes (HaCat), each compound caused a decrease in cell
viability with concentrations above 40 μM. At a concentration of 30 μM, compounds 3
and 4 caused reductions in cell viability by approximately 12.42% and 17.92%,
respectively. Compound 3 was able to decrease viability by as much as 93.63% at 50
μM. Lastly, in SH-SY5Y cells, all of thecompounds (1–5) induced a cytotoxic effect at
concentrations of 50 μM and above.
Lastly, for the first time, a qualitative analysis of the flavonoids present in a
methanol extract of the aerial parts of E. saudiarabica using LC-ESI-TOF-MS/MS was

conducted. This led to the identification of 36 flavonoids including 7 flavonoids based
on the galangin aglycon, 9 flavonoids based on the apigenin aglycon, and 20 flavonoids
originated from luteolin.
In conclusion, this dissertation provids insights about the phenolic constituents,
primarily tannins, of silver maple (Acer saccharinum), compared to other common
maple species, mainly the sugar (A. saccharum), red (A.rubrum), and sycamore (A.
pseudoplatanus) maples which were previously investigated by our group. In addition,
the endemic Euphorbia saudiarabica species from Saudi Arabia yielded five new
lathyrane-type of diterpenoids. All compounds evaluated for their cytotoxicity showed
moderate effects. Lastly, a rapid and reliable method employing LC-ESI-TOF-MS/MS
was developed for the identification of flavonoids in the aerial parts of E. saudiarabica.
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PREFACE
This dissertation is written based on the University of Rhode Island
“Guidelines for the Format of Thesis and Dissertations” standards for the manuscript
format. This dissertation is composed of three manuscripts to satisfy the requirements
of the Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy,
University of Rhode Island.
MANUSCRIPT І: Bioactive Glucitol-Core Containing Gallotannins and Other
Phytochemicals from Silver Maple (Acer saccharinum) Leaves.
This manuscript was published in Natural Products Communication, 2017.
The objective of this work was to investigate the secondary metabolites, primarily
polyphenolic compounds, and especially, gallotannins. The presence of unique
gallotannins-type compounds in several maple species, including sugar, red, and
sycamore species, and their bioactivities, prompted us to seek for new gallotannin
compounds and/or known compounds from silver maple leaves.

MANUSCRIPT II: Saudiarabicain A–E, Macrocyclic Diterpenoids from
Euphorbia saudiarabica.
This manuscript will be submitted to the Journal of Natural Products.
In this work, we investigated the phytochemical constituents of an endemic species from
Saudi Arabia called Euphorbia saudiarabica. The genus Euphorbia is well known for
its richness of secondary metabolites, primarily diterpenes, in their latex. The aerial parts
of the plant were collected in 2014 in Saudi Arabia, where they are located in a colony
close to the Red Sea. Next, it was extracted using methanol and sent to our laboratory
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for further investigation. Several steps of purification and structure characterization
were conducted, resulting in the isolation of five new diterpenoids compounds named
saudiarabicains A–E. These compounds were evaluated for their cytotoxicity against
three cell lines including murine B16F10 melanoma cells, human HaCat keratinocytes,
and human SH-SY5 neuroblastoma cells.

MANUSCRIPT III. Liquid Chromatography Coupled with Time-of-Flight
Mass Spectrometry for Rapid Identification of Flavonoids from Aerial Parts
of Euphorbia saudiarabica
This manuscript will be submitted to the Journal of Separation Science.
This work focused on the phenolic contents, mainly flavonoids, of Euphorbia
saudiarabica. The methanol extract of the plant was investigated using LC-ESI-TOFMS/MS.
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INTRODUCTION
All organisms are required to produce many organic compounds to enable
them to live, grow, and reproduce. These organisms, such as plants, need to supply
themselves with energy and sufficient amounts of building blocks to build up their
tissues. Vast quantities of enzymes are involved in accelerating and regulating the
chemical reactions that take place in organisms, and the pathways involved are
called metabolic pathways. Carbohydrates, proteins, fats, and nucleic acids are some
of the essential molecules for all organisms. Organisms differ broadly in their ability
to synthesize and transform chemicals; plants are well known for their highly
efficient synthesis of organic molecules. They produce these molecules through
photosynthesis, a process through which light energy is converted into chemical
energy that can be used to fuel energy transformations when they are needed later
on. This diverse array of organic molecules, essential to plants, are called
metabolites (1).
There are two types of metabolites: primary and secondary. The primary
metabolites are all those organic compounds that are primarily involved in
synthesizing and modifying the fundamental compounds of the plants including
carbohydrates, proteins, fats, and nucleic acids, which are essential for vital
processes such as glycolysis, fatty acid oxidation, carbohydrate degradation, etc.
They, in other words, are all the metabolites that are directly involved in a plant’s
normal growth, reproduction, and development. By contrast, the secondary
metabolites have a much more limited distribution within the plant kingdom (2).
Moreover, these types of metabolites are not necessarily produced in all plants
because they are not directly involved in the plants’ vital processes. Although the
benefits of these compounds are not yet known, there are nonetheless some plausible
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reasons for plants to have these types of metabolites. They include providing defense
against predators by producing toxic compounds and warning other species by
producing coloring agents. Biosynthetically, secondary metabolites are derived from
primary metabolites through many complex biochemical pathways. These
metabolites can be found in any of the plants’ organs, such as their leaves, stem,
bark, or roots. However, they may vary in their concentration based on their location
in the plant. The secondary metabolites are also known as natural products (3).
Most of the pharmacological effects of a specific plant on humans or animals
are due to the presence of one or more of these natural products, which are called
bioactive natural products. The pharmacological effects of these products are many,
such as therapeutic activities for diseases, or toxic activities responsible for human
or animal illnesses. Furthermore, based on the secondary metabolites’ biosynthetic
origins and their chemical structure, there are three main classes of compounds:
terpenes and steroids, phenolics, and nitrogen-containing compounds (Fig. 1) (1,3,4).

Terpenoids and steroids

Natual prodcuts
(Secondary metabolites)

Phenolics
Nitrogen-containing compounds

Figure 1. The main classes of natural products.
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1-

Phenolic compounds
Plants produce a vast variety of natural products such as phenolics, which

contain a phenolic group that is chemically heterogeneous. Some of them are water
soluble, others are soluble in organic solvents, and some are insoluble polymers.
These phenolics have a very broad range of physiological roles in plants. For
instance, some phenolics serve as a defense system against environmental stresses,
including herbivores, pathogens, low temperatures, and nutrient deficiency.
Phenolics arise biosynthetically via several different routes; however, the most
important ones are the shikimic acid and malonic acids pathways. The shikimic acid
pathway is the main route to produce most of the plant phenolics. It begins with a
coupling of two start molecules: phosphoenolpyruvate (PEP) from the glycolytic
pathway, and D-erythrose 4-phosphate from the pentose phosphate cycle. These two
molecules produce a six-cyclic carbon compound with one carbon (COOH) side
chain, namely shikimate, through an aldol-type condensation reaction. Then, several
other complex transformations are formed to produce many different phenolic types
(Fig. 2) (5).

Non-flavonoids

-Coumarins
-Stilbenes
- Phenolic acids
- Lignans
- Tannins, etc.

Phenolic
Compounds

Flavonoids

-Flavones
-Flavonols
-Anthocyanins
-Isoflavones, etc.

Figure 2. The main classes of phenolic compounds.
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Tannins are a unique group of phenolic compounds called non-flavonoids,
which have the capability to bind strongly with other secondary metabolites such as
alkaloids, polysaccharides, and proteins. There are four main kinds of tannins,
including:
1. Gallotannins, which are hydrolyzable tannins that galloyl units are
attached to via several polyol residues.
2. Ellagitannins, which are hydrolyzable tannins. At least two galloyl units
are attached to each other (C-C coupled) and are linked to D-glucosyl
units.
3. Complex tannins, which are built up from a combination of either a
gallotannin, a ellagitannin unit, or both, and a catechin unit.
4. Condensed tannins, which are polymers of polyhydroxy-flavan-3-ol
monomers (also known as proanthocyanidins). (6,7)
Many of these tannins can be found in grape seeds, apple juice, strawberries,
raspberries, pomegranates, walnuts, muscadine grapes, peaches, blackberries, etc.
Flavonoids and their conjugate forms are one of the most abundant
polyphenols; over 8000 different flavonoids have been reported. In addition, they
are considered to be the most plentiful of natural products in human diet since they
are found in many plant tissues, including fruits and vegetables. The basic chemical
structure of flavonoids is a skeleton of diphenylpropane connected by a three-carbon
chain “bridge” which is biosynthetically derived from two different pathways: the
shikimic acid pathway and malonic acid pathway. The three carbon chain bonds with
one oxygen linked to form a pyran ring (heterocyclic ring) with one phenyl ring
(malonic acid derived) to eventually form the benzopyrano ring moiety. Therefore,
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the skeletal structure of the flavonoid can be abbreviated C6-C3-C6 (Fig. 3). Thus,
according to the position of the bond of the aromatic ring to the

Figure 3. The skeletal structure of the flavonoids.
benzopyrano moiety and the degree of oxidation of the three-carbon chain, this
flavonoid can be divided into four main classes: the anthocyanins, the flavones, the
flavonols, and the isoflavones (Fig. 4) (8).

Figure 4. The skeletal structure of the four main classes of the flavonoid
compounds.

2- Terpenoid compounds
The terpenoids, or the terpenes, are one of the most diverse classes of secondary
metabolites. Most of them are known for their water insolubility. All terpenoids are
5

synthesized from acetyl-CoA or its glycolytic intermediates. Based on the number
of isoprene units (C5) that are linked to each other, several sub-class of terpenes are
produced as follows:
A- Monoterpene compounds (C10) are formed from an infusion of two
isoprene units such as menthol and linalool.
B- Sesquiterpene compounds (C15) are composed of three isoprene units.
C- Diterpene compounds (C20) are formed from four isoprene units.
D- Triterpene compounds (C30) are formed from six isoprene units.
E- Tetraterpene compounds (C40) are composed by the fusion of eight
isoprene units.
These terpenes are synthesized from primary metabolites by either the mevalonic
acid pathway (MVA) or the methylerythritol phosphate (MEP) pathway. Most of the
plant diterpenes, such as Euphorbia genus diterpenes, are produced through the MEP
pathway. Most of the terpenes are known for their vital roles in plant growth,
development, and defensive systems. Some of them are considered primary
metabolites rather than secondary metabolites due to their fundamental role in plant
life. For instance, sterols are essential components of cell membranes (9).
Diterpenes biosynthetically arise from their geranylgeranyl diphosphate
(GGPP) precursors, which are initially derived from four isoprene units. They can
be found in two main types, which are:

Figure 5. The chemical structure of geranylgeranyl diphosphate (GGPP)
precursor.
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-

Acyclic diterpenoids, such as phytol, the reduced form of geranylgeraniol
that form the side-chain of the chlorophylls, and phytyl, which is found in
vitamin K.

-

Cyclic diterpenoids, which are also subdivided into different types based on
the number of rings systems present. For example, there are bicyclic
diterpenoids such as labdane, tricyclic diterpenoids such as taxadiene, and
tetracyclic diterpenoids such as stemodene (Fig. 6) (10).

Labdane

Taxadiene

Stemodene

Figure 6. Different type of cyclic diterpenoids.
These different types of cyclized diterpenoids are generated through different
cyclization reactions of GGPP, which are mediated by carbocation formation, as
well as by the potential of Wagner-Meerwein rearrangements. For instance,
paclitaxel (an anti-cancer drug) starts by generating carbocation form at the
beginning of the reaction (Fig. 7).

Taxol

Figure 7. Reaction mechanism for the cyclization of GGPP
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Diterpenoids can be found either in higher plants or fungi. For example, phytol is
widespread in higher plants, where it binds to chlorophyll structures. Most
diterpenoids are restrictively distributed and are rarely attached to sugar moieties to
form glycosidic diterpenoids. If it is present, it is recognized as a sweetening agent.
3- Nitrogen-containing compounds
Many secondary metabolites have a nitrogen atom as part of their chemical
structure. They include alkaloids, cyanogenic glycosides, glucosinolates, and nonprotein amino acids. Alkaloids, the most abundant N-containing natural products,
and are found in more than 20% of plants. Usually, the nitrogen atom is part of the
cyclic rings. Alkaloids synthesized mainly from amino acids are mostly lysine,
tryptophan, or tyrosine. Furthermore, the carbon skeleton of many alkaloids can be
derived biosynthetically from a terpene pathway. They can be produced by different
organisms such as fungi, bacteria, and animals. Depending on the chemical features
of the compounds, alkaloids can be classified into seven main types (Fig. 8) (2).

Figure 8. The main classes of alkaloids.
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Phytopharmacological investigation of maple (Acer) species
Our laboratory has previously isolated a series of natural α-glucosidase
inhibitory gallotannins, named maplexins A–I, from the red maple (Acer rubrum)
species

(11,12)

. These compounds contained mono-, di-, and trigalloyl substituents

located at different positions on a 1,5-anhydro-D-glucitol moiety. Interestingly, the
α-glucosidase inhibitory activities of these maplexins increased with the number of
galloyl substituents, and a trigalloyl-substituted maplexin (maplexin E) was 20-fold
more potent than the clinical drug acarbose (Fig. 9) (12).

Figure 9. The chemical structure of maplexins A–I
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Phytopharmacological investigation of Euphorbia species
The Euphorbiaceae family is among the most prominent families of the higher
plants, and is composed of more than 300 genera and 7000 species subdivided into
many subgenera and sections (13). Among this family, the Euphorbia genus is one of
the three largest genera of flowering plants, with approximately 2000 species

(14)

.

The Euphorbia species all produce a mostly white latex, which is often rich in
secondary metabolites, some of which are considered toxic. Several Euphorbia
species have been used in ethnomedicine as purgatives and as treatments for asthma,
tumors, and warts. (13) It is also well known for producing various types of secondary
metabolites, primarily diterpenes, with immense chemical diversity (15). Diterpenes
occurring in the Euphorbia species are of considerable interest from the perspective
of natural product drug discovery because of their wide range of unique biological
activities and their high structural diversity. They have been reported to show a broad
range of in vitro and in vivo biological properties, including multidrug resistance
(MDR) modulator, antimicrobial, and anticancer agents. The importance of
diterpenes from the Euphorbiaceae family is highlighted by the approval granted by
the US Food and Drug Administration in 2012 for the treatment of actinic keratosis,
a precancerous skin condition, of ingenol 3-angelate (ingenol mebulate, PEP005,
Picato®, LEO pharma) (16). Ingenol mebutate is a substance derived from the sap of
the plant Euphorbia peplus. The high presence of active diterpenes in the latex of
many Euphorbia species is well known. Diterpenoids are the majority secondary
metabolites of the Euphorbia genus with many different skeletons, such as
jatrophanes, ingenane, and lathyranes (Fig. 10), as well as sesquiterpenoids,
flavonoids, and steroids. Previous publications on diterpenoids isolated from
Euphorbia species have revealed novel compounds with promising cytotoxicity and
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MDR modularity effects, such as macrocyclic lathyrane and jatrophane diterpenes
(13)

. Also, several structure-activity relationship studies on Euphorbia species have

revealed that the diterpenoids with the jatrophanes and lathyrane pharmacophore are
very active MDR modulators due to the high conformational flexibility of their 11,
12-membered rings (Fig. 10)

(17)

. A recent study also has shown that some

Euphorbia species like E. resinifera and E. bicolor possess different structural
compounds with various biological properties, such as an analgesic activity (18).

Figure 10. The skeletal structure of three types of Euphorbia diterpenoids.
A recent study has shown that the number of publications on the Euphorbia
species increased by about 40% from 2012 to 2013 (14). In the past few years, several
researchers have revealed that Euphorbia diterpenes with different skeletal types
(such as tigliane, lathyrane, myrsinane, and jatrophane) have exhibited moderate or
strong antiproliferative effects on different human cell lines (e.g., pancreatic, lung,
skin, ovarian, and colon carcinomas). Some of these diterpenes have been
demonstrated as cytotoxic compounds, and other as apoptosis inducers. For
example, several lathyrane diterpenoids isolated from Euphorbia nivulia exhibited
strong cytotoxicity effects against Colo205, MT2, and CEM cell lines

(19)

. Many

other diterpenes types, such as jatrophane, ingenane, premyrsinane and
cyclomyrsinane derivatives, have shown potent cytotoxicity effects against various
human cancer cell lines. A recent study has indicated that some jatrophane
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diterpenes showed synergistic interactions with the anticancer drug doxorubicin (20).
This dual action was the result of the high flexibility of this macrocyclic diterpene.
Several Euphorbia diterpenes have been proposed to circumvent MDR to
enhance the efficacy of drugs. Among those, the jatrophane- and lathyrane-type
macrocyclic diterpenes from Euphorbia species have been described as strong
MDR-reversing compounds by the modulation of the P-gp protein

(21)

. These

promising findings led to the development in the in silico studies, as well as
structure-activity relationship studies, to identify their pharmacophore structure and
to optimize their efficacy. Findings indicate that P-gp inhibition contributes to the
mechanisms of P-gp translocation, thereby enhancing the drug accumulation inside
the cells. Therefore, the discovery of MDR modulators becomes a valuable
therapeutic target for combating the progression of cancer diseases by enhancing the
efficacy of anticancer agents and reducing the side effects that come with long
chemotherapy treatments or ineffective treatments (22).
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2. The Justification and Significance of the Study
Natural products are continuously inspiring new drug targets and
synthetic scaffolds. Between 1940 and 2010, a total of 175 small-molecule, anticancer therapeutics have been accepted by the Food and Drug Administration. Of
those 175 approved therapies, 49% were either discovered or derived directly from
a natural product (23). Even with natural products providing such significant impacts
towards the generation of new pharmaceuticals, there is still a growing demand for
the discovery of new lead compounds. This cycle puts continuous pressure on
finding novel compounds and sources for drug candidates.

A- Silver maple (Acer saccharinum)
The incidence of type 2, or non-insulin dependent, diabetes mellitus is
increasing rapidly worldwide and has become a significant public health burden (24).
Among various strategies used for type 2 diabetes management, clinical αglucosidase inhibitory drugs, such as acarbose, are used to block the activity of
carbohydrate-hydrolyzing enzymes thus decreasing postprandial hyperglycemia (25).
Over the past years, there has been renewed scientific attention in identifying
natural plant-based α-glucosidase inhibitors for the treatment and management of
diabetes. Therefore, silver maple has not been previously investigated for all of its
polyphenolics content. Only two compounds were identified previously from silver
maple which are Gramine and methyl-gallate (Fig. 11). As the total polyphenolic
content level in silver maple leaves is high, it seems reasonable to investigate the
chemical constituents in the leaves, which could also serve as α-glucosidase
inhibitors. Therefore, a phytochemical study is proposed to isolate and identify
known or undiscovered phenolic compounds from silver maple leaves and evaluate
13

these compounds for antioxidant and anti-diabetic activities. This study also
proposes to elucidate the chemical structures of new compounds by using various
techniques.

Scientific classification of silver maple
Kingdom

Plantae

Order:

Sapindales

Family:

Sapindaceae

Genus:

Acer

Species:

A. saccharinum

Table 1. The scientific classification of silver maple.

Figure 11. Structures of chemical constituents previously identified in silver maple.
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B- Euphorbia saudiarabica.
The importance of Euphorbia species has increased in the last five years, and
the number of publications in this period has shown that this genus is producing a
large number of promising bioactive compounds, mainly diterpenoids. Few of the
Euphorbia species have been investigated thus far. In Saudi Arabia, for example,
there are about 40 Euphorbia species, of which many are uninvestigated or poorly
investigated; five of these are endemic, such as E. saudiarabica

(26)

. Therefore, the

Euphorbia saudiarabica species was chosen for investigation of its phytochemical
and biological activities.
Euphorbia saudiarabica was identified in 2007 and is endemic to the
southwestern region of Saudi Arabia along the Albirk-Jazan road (Fig. 12) (27). It is
a small tree that resembles as a candelabra-like succulent spiny shrub and does not
exceed 3 meters in length. It produces a strong, white, skin-irritant latex. The aerial
part of the plant was collected, dried, and extracted with methanol in order to screen
their phytopharmacological properties. Approximately 123 g of methanolic extract
was obtained from King Khalid University through a Materials Transfer Agreement
with the University of Rhode Island.

A

B

Figure 12. (A) Map of Saudi Arabia (B) The aerial part of Euphorbia saudiarabica
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3. The Objectives of the Study
The objective of this study is to isolate and evaluate the phytochemical
compositions and the pharmacological properties of two higher plants, silver maple
(Acer saccharinum) and Euphorbia saudiarabica, through the following aims:

•

Aim 1 Phytochemical investigation of the silver maple leaves and the
aerial part of Euphorbia saudiarabica using different isolation and
purification processes, such as open column chromatography (OCC), thin
layer chromatography (TLC), medium pressure liquid chromatography
(MPLC), and high-performance liquid chromatography (HPLC), etc.

•

Aim 2 The pure compounds will be isolated, and then the structure of all
compounds will be elucidated using several techniques, including IR, UV,
HR-ESIMS, NMR, and experimental ECD.

•

Aim 3 Biological activities evaluation of all isolated phytochemicals will be
conducted using different bioassays, such as cytotoxicity.

•

Aim 4 The flavonoids composition of Euphorbia saudiarabica crude extract
will be examined using LC-ESI-TOF-MS/MS.
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Abstract
In the course of our group’s investigation of members of the maple (Acer) genus, a
series of glucitol-core containing gallotannins (GCGs) were isolated and identified
(by NMR and HREISMS). Among higher plants, only certain maple species are
known to produce GCGs, compounds with potential nutraceutical and cosmetic
applications due to their reported antioxidant, antidiabetic, anti-α-glucosidase, antiglycation, anticancer, and skin health promoting effects. Herein, we sought to
investigate whether the previously un-investigated silver maple (Acer saccharinum)
species was also a source of GCGs. Nine phenolic compounds, including six GCGs,
were identified (by HPLC-DAD analyses using previously isolated standards) as
ginnalins A-C (1-3), maplexins B, D, and F(4-6), methyl syringate (7), methyl
gallate (8), and 3-methoxy-4-hydroxyphenol-1-β-D-(6 galloyl)-glucopyranoside (9).
In addition, one sesquiterpenoid, namely, pubineroid A (10), was isolated and
identified (by NMR).

Keywords: Silver maple, Acer saccharinum, Phenolic, Glucitol-core containing
gallotannins (GCGs).
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Introduction
The maple (Acer) genus contains thirteen species which are native to North America
including the sugar (A. saccharum), red (A. rubrum), and silver (A. saccharinum)
maples. Apart from sap which is primarily consumed as maple syrup [1], other maple
plant parts (leaves, bark, etc.) have also been used as traditional medicines by the
indigenous people of North America [2]. Our group has reported on the isolation and
structure elucidation (by NMR and HREISMS) of over 70 phytochemicals, from the
sugar, red, and sycamore (A. pseudoplatanus) maples [3-7]. Among these species,
only the red maple yielded glucitol-core containing gallotannins (GCGs) [3, 4, 6].
These compounds have been reported, by our group [8-15], and others [16-20], to
show a wide range of in vitro and in vivo biological effects including, antioxidant,
anti-diabetic, anti-α-glucosidase, anti-glycation, anticancer, and skin-health
promoting effects. Given the potential nutraceutical and cosmetic applications of
these compounds, as well as our access to the aforementioned maple-derived
phytochemical standards, herein, we sought to investigate whether the silver maple
was a source of GCGs. Using authentic standards (previously isolated by our
laboratory), nine phenolics, including six GCGs, were identified from silver maple
leaves as ginnalins A-C (1-3), maplexins B, D, and F (4-6), methyl syringate (7),
methyl

gallate

(8),

and

3-methoxy-4-hydroxyphenol-1-β-D-(6-galloyl)-

glucopyranoside (9) (by HPLCDAD analyses, see Supplementary data, Table S1)
[6, 7]. In addition, one sesquiterpenoid, namely, pubinernoid A (10), was isolated
and identified (by NMR; see Supplementary data, Figures S1 and S2). Pubinernoid
A was obtained as a white amorphous powder and its 1H and
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C NMR data were

consistent with the literature [7]. The chemical structures of the compounds
identified from silver maple leaves are shown in Figure 1. In summary, this is the
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first reported phytochemical investigation of the silver maple which led to the
identification of nine phenolic compounds (six GCGs and three phenolics) and a
sesquiterpenoid. Our findings add to the growing body of data of phytochemicals
identified from the maple (Acer) genus, and more importantly, about which maple
species produce GCGs, a promising class of bioactive plant polyphenols with
nutraceutical and cosmetic applications.
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Figure 1: Chemical structures of compounds 1-10.
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Experimental
General: High performance liquid chromatography (HPLC) analyses were
performed on a Hitachi Elite LaChrom system consisting of a L-2130 pump, a L2200 autosampler, and a L-2455 Diode Array Detector. All 1H and 13C NMR
spectra were acquired on a Bruker 300 MHz spectrometer using MeOD4 as solvent.
Plant material: Silver maple (Acer saccharinum) leaves were collected on the
Kingston campus of the University of Rhode Island (Kingston, RI, USA) in the
summer of 2010 and were botanically authenticated by Mr. J. Peter Morgan.
Voucher specimens (16JPM1-APS6310) are deposited in the Heber-Youngken
Garden and Greenhouse at the College of Pharmacy, University of Rhode Island.
Extraction of plant material: Air-dried silver maple leaves (1007.8 g) were
macerated for 9 days with MeOH (5.5 L× 3). The filtrate was concentrated under
reduced pressure to afford a dried methanol extract (250 g). This was suspended in
distilled water and successively partitioned to yield n-hexanes (67.5 g), ethyl acetate
(EtOAc; 28.7 g), and n-butanol (37.5 g) extracts after solvent removal in vacuo. The
EtOAc extract, which contained the highest total polyphenol content (58.8% GAEs
based on the Folin-Ciocalteau assay, see Supplementary data, Table S2), was
selected for further phytochemical investigation (described below).

Identification of compounds 1-9 in the EtOAc extract of silver maple leaves by
HPLC-DAD analyses: The EtOAc extract (5 mg) was analyzed on a Phenomenex
C18 column (250 × 4.6 mm, i.d. 5 μm). The injection volume was 10 μL and the
flow rate was 0.75 mL/min. A gradient mobile phase solvent system consisting of
solvent A (0.1% aqueous trifluoroacetic acid) and solvent B (MeOH) was used as
follows: 0-50 min, 5%-46% B. The HPLC profile was monitored at 220 nm and
25

compounds 1-9 were identified by comparison of their retention times to authentic
standards previously isolated by our laboratory from red maple [3, 4, 6].
Isolation of compound 10 from the EtOAc extract of silver maple leaves: Having
identified the major constituents in the EtOAc extract which were phenolics (1-9),
we attempted to isolate the (minor) non-phenolic constituent/s (based on UV
absorbance; see Supplementary Data, Table S1) present in the extract. Briefly, the
EtOAc extract (28.2 g) was purified on a silica gel column eluted with a gradient
solvent system of chloroform/MeOH (50:1 - 1:1; v/v) to afford 11 fractions (F1 F11). Fraction F3 (440 mg) was chromatographed on a Sephadex LH-60 column
eluting with MeOH to afford 6 sub-fractions (13A - 13F). Fraction 13B (340 mg)
was chromatographed on a silica gel column eluting with a gradient solvent system
of hexane/dichloromethane (10:0 - 0:10; v/v) to afford 5 fractions (16A - 17C).
Fraction 16C (15 mg) was further purified by C18 reversed-phase semi-preparative
HPLC with a mobile phase consisting of MeOH and 0.1% aqueous trifluoroacetic
acid (60:40; v/v) to afford compound 10 (3.4 mg, tR =12.2 min).

Supplementary data: Supplementary data are available for this article and available
free of charge.
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Abstract
Methanol extracts of aerial parts of Euphorbia saudiarabica afforded five new
macrocyclic-lathyrane diterpenoids, named saudiarabicain A–E (1–5). 1 and 2
represent an unusual type of lathyrane diterpenoids. Structures of 1–5 were
determined by analysis of extensive NMR and mass spectroscopic data, and the
relative configuration of all compounds (1–5) were established by NOESY spectra
analysis. Diterpenoid 2 showed a significant cytotoxicity effect against B16F10 murine melanoma cells, while the remaining compounds exhibited only
moderate or no cytotoxicity activity against B16F10, human HaCat keratinocytes,
and human SH-SY5Y neuroblastoma cells.

Saudi Arabia

E. saudiarabica
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Introduction
The Euphorbiaceae family is among the largest families of higher plants,
composed of more than 300 genera and 7000 species subdivided into many
subgenera and sections1. Among this family, the Euphorbia genus is one of the three
largest genera of flowering plants, with approximately 2000 species2. The
Euphorbia species all have milky irritant latex that is often rich in secondary
metabolites; some of them are considered toxic. Several E. species have been used
in ethnomedicine as purgatives and as treatments for asthma, tumors, and warts 1. It
is also well known for producing various types of secondary metabolites, primarily
diterpenes, with immense chemical diversity3. Diterpenes occurring in the
Euphorbia species are of considerable interest from the perspective of natural
product drug discovery because of their wide range of unique biological activities
and their high structural diversity.
The importance of diterpenes from the Euphorbia genus is highlighted by the
approval granted by the US Food and Drug Administration in 2012 for the treatment
of actinic keratosis, a precancerous skin condition, for ingenol 3-angelate (ingenol
mebulate, PEP005, Picato®, LEO pharma) 4. Diterpenoids are the majority
secondary metabolites of the Euphorbia genus with many different skeletons such
as jatrophanes, ingenane, and lathyranes, as well as sesquiterpenoids, flavonoids,
and steroids5. Previous publications on diterpenoids isolated from Euphorbia species
have revealed novel compounds with promising cytotoxicity and multi-drug
resistance (MDR) modularity effects, such as macrocyclic lathyrane and jatrophane
diterpenes1. Also, several structure-activity relationship studies on Euphorbia
species have revealed that the diterpenoids with the jatrophanes and lathyrane
pharmacophore are very active MDR modulators due to the high conformational
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flexibility of their 11, 12-membered rings6.
Herein, we report the isolation and characterization of five new lathyrane-type
diterpenoids named saudiarabicain A–E (1–5) from the aerial part of Euphorbia
saudiarabica. E. saudiarabica is an endemic plant in Saudi Arabia and mainly
distributed in the southwestern area of that country, close to the Red Sea.
Furthermore, we evaluated the cytotoxicity effects of these compounds using three
different cell lines.
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RESULTS AND DISCUSSION
Compound 1 was obtained as white amorphous powder and had molecular formula
C31H40O11 as deduced by (+)-HRESIMS ion at m/z 633.2332 [M + Na]+ (calcd
633.2312). The 1H NMR and

13

C NMR Data of compound 1 (Table 1) revealed

three acetyl moieties and one benzoyl group (δC 170.5, 133.3, 129.5, 129.3, 128.5;
δH 7.99, 7.55, 7.42). The remaining 20 carbons, building the lathyrane-type diterpene
core structure, contained a rare oxymethine, four methyls, one cis C=C bond and one
ketone carbonyl group7. . Their connections were deduced from correlations
observed in the 1H-1H COSY and HMBC spectrum. Three spin systems were
established

by

1

H-1H

COSY

correlations:

H-1/H-2/H-3,

H20/H13/H12/H11/H9/H8/H7 and H4'/H3' (Fig. 2A). The carbonyl group at C-14
was determined by the long-range correlations of H-20 to C-14 and H-13 to C-14,
which observed in the HMBC spectrum. The HMBC correlations of H-1 to C-4 and
H-3 to C-15 supported the locations of the two oxygenated quaternary carbons: C-4
and C-15. The assignment of the oleﬁnic proton H-5 at δH 5.43 was determined by
the HMBC correlation of H-5 to C-15. The HMBC correlations of H-19 to C-9, C12, and C-18, combined with the chemical shift of C-19 (103.1), supported the
identification of the rare oxygenated C-19. The locations of the acetyl moieties were
assigned by the HMBC correlations which showed in Fig. 2A. The planar structure
of 1 was deduced as shown in Fig. 2A. The relative stereochemistry of 1 was
assigned by NOESY correlations as shown in Fig. 2B. H-2, H-1α, H-3, H9, H-11,
and H-19 were assigned randomly as α-oriented based on the NOESY correlations
of H-2/H-1α, H-2/H-3, H-9/H-11, and H-11/H-19. Consequently, H-7, H-8, H-12,
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and H-13 were assigned as β-oriented by NOESY correlations of H-7/H-8, H-8/H12, and H-12/H-13 (Fig. 2B).
Compound 2 showed a (+)-HRESIMS [M + Na]+ ion peak at m/z 611.2495 (calcd
for C33H38O11Na, 611.2468). Analysis of NMR spectra data suggested that the
structure of compound 2 was closely related to compound 1 (Table. 1). The only
major differences in the NMR data of compound 2 is the presence of angelate group
signals instead of benzoyl group as it was in compound 1. (Fig. S1, supporting
information).
The HRESIMS of compound 3 showed a sodiated molecular ion at m/z 691.2751
[M + Na] +, corresponding to the molecular formula of C36H44O12 (calcd, 691.2730).
The 1H and 13C NMR data (Table 1) of 3 revealed the lack of chemical shift of C19 (103.1), which indicate that 3 is clearly different from 1 and 2. Analysis of 1H
and 13C NMR revealed four acetoxy groups and one benzyl group (δc 170.5, 134.1,
129.1, 128.2, 126.8, 40.7; δH 7.20, 3.65). The remaining 20 carbons, building the
lathyrane-type diterpene core structure, contained one cis C=C and one ketone
carbonyl group8. Their connections were deduced by 1H-1H COSY and HMBC
spectra. Two spin systems were established by 1 H-1H COSY correlations: H-1/H2/H-3 and H-20/H13/H-12/H-11/H-9/H-8/H-7 (Fig. 2C). The carbonyl group at C14 was determined by the long-range correlations of H-20 to C-14 and H-13 to C14, which was observed in the HMBC spectrum. The HMBC correlations of H-1 to
C-4, H-3 to C-15 supported the locations of the two oxygenated quaternary carbons:
C-4 and C-15. The oleﬁnic proton H-5 at the δH 5.43 location was determined by the
HMBC correlation of H-5 to C-15. The correlations of H-7 to phenylacetoxy
carbonyl (δC 170.5) revealed that the phenylacetoxy group was located at C-7. The
presence of acetoxy groups at C-3, C-8, C-12, and C-19 was suggested by HMBC
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correlations between acetoxy carbonyls and H-3, H-8, H-12, and H-19, respectively.
(Fig. 2C). The relative configuration of 3 was established by NOESY correlations.
H-2, H-1α, H-3, H-9, H-11, and H-18 were assigned randomly as α-oriented on the
basis of NOESY correlations of H-2/H-1α, H-2/H-3, H-9/H-11, and H-9/H-18.
Consequently, H-7, H-8, H-12, and H-13 were assigned as β-oriented by NOESY
interactions of H-7/H-8, H-8/H-12, and H-12/H-13 (Fig. 2D).
Compound 4 was obtained as a white amorphous powder. The 1H NMR and 13C
NMR data of 4 (Table 2) were quite similar to those of 3. Comparison between the
1

H NMR spectrum of 3 and 4 showed a difference only in the ester moieties. The 1H

NMR and 13C NMR spectrum of 4 revealed the presence of one benzoyloxy group,
one angelate group, two acetoxy groups, and a free hydroxyl. In the HMBC
spectrum, the carbonyls of the benzoyloxy, one angelate group, and two acetoxy
groups displayed cross-peaks with H-8, H-7, H-12, and H-19, indicating the groups
located at C-8, C-7, C-12, and C-19, respectively. The free hydroxyl was located at
C-3 because of the HMBC correlation between the free hydroxyl and C-3. By
comparing the NMR data of 5 (Table 2) with those of 4, we deduced the structure
of 5, which is the same as that of compound 4 except for the benzoyloxy group at C8 in 4 that is replaced by the angelate group in 5.
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Figure 1: Chemical structures of compounds 1–5.
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Figure 2. (A and C) Key HMBC and COSY (bold bonds) for compound 1 and 3, respectively. (B
and D) NOESY correlations for compound 1 and 3, respectively.
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Table 1. 1H NMR and 13C NMR data (300 and 75 MHz, CD3OD) for compounds 1–3
1

2

no.

δH (J in Hz)

1α

2.56 dd (15.0, 9.0)

1β

1.67 d (15.0)

2

2.34 m

29.2

2.36 m

29.3

2.41 m

29.3

3

5.03 d (8.4)

77.1

5.06 d (8.4)

77.1

5.13 d (8.7)

76.8

4
5

δC
34.1

3

δH (J in Hz)

δC

δH (J in Hz)

2.59 dd (14.7, 9.0)

34.1

2.70 dd (14.7, 9.0)

1.72 d (15.0)

73.3
5.70 s

6

116.7

1.60 d (14.7)

73.3
5.53 s

142.1

δC
31.1

116.4

71.0
5.43 m

142.4

117.6
138.7

7

5.45 brs

77.2

5.22 brs

77.1

5.04 d (1.8)

76.4

8

5.02 dd (11.2, 1.2)

70.2

4.92 d (11.1)

70.2

4.54 dd (10.8, 1.8)

70.7

9

1.61 dd (10.8, 9.0)

27.2

1.46 dd (10.8, 9.0)

27.2

1.30 dd (10.8, 9.0)

25.0

10

33.0

32.7

21.6

11

1.34 dd (8.7, 1.5)

31.0

1.25 m

30.9

1.15 dd (11.1, 9.0)

30.9

12

4.65 dd (4.5, 1.5)

78.1

4.58 d (4.8)

78.0

4.84 dd (11.1, 7.8)

69.4

13

3.34 qd (6.6, 4.5)

48.7

3.30 qd (6.9, 5.1)

48.7

2.82 dq (7.5, 7.2)

14

206.4

15

206.4

72.9

43.0
207.0

72.9

73.4

16

0.84 d (7.2)

16.0

0.84 d (7.5)

16.0

0.84 d (7.5)

15.9

17

2.08 s

16.6

1.97 d (1.8)

16.5

1.96 d (1.5)

16.2

18
19

1.25 s
6.13 s

17.0
103.1

1.20 s
6.03 s

17.0
103.0

1.00 s
19α: 4.01 d (12.0)
19β: 3.46 d (12.0)

23.2
64.7

20

0.96 d (6.6)

6.8

0.93 d 6.6

6.8

0.92 d (7.2)

12.4

3-OAc

170.5

170.5

170.6

1.99 s

19.1

1.97 s

19.0

2.00 s

1.87 s

170.6
19.5

1.98 s

170.7
19.9

1.94 s

8-OAc
12-OAc

1.89 s
19-OAc

170.8
2.01 s

19.9

7-R

O-Bz

C=O

170.5

1'

129.5

170.6
1.84 s

19.5
OAng
166.5

19.7
170.4
19.0
170.8
19.33
171.3

1.88 s

19.5
O-Bzl
170.5
134.1

2'

7.99 m

129.3

3'

128.5

6.86 q (6.6)

138.4

133.3

1.74 d (6.6)

13.2

128.2

5'

7.42 ddd (7.2, 7.2, 1)
7.55 dddd (7.5, 7.5,
1.5, 1.5)
7.42 ddd (7.2, 7.2, 1.5)

128.5

1.76 s

10.8

126.8

6'

7.99 m

129.3

-

-

7'

-

-

-

-

4'

128.0
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129.1
7.20 5H m

126.8

129.1
3.65 s

40.7

Table 2. 1H NMR and 13C NMR data (500 and 125 MHz) for compounds 4–5 (4 in DMSO-d6, 5 in CD3OD).
4
no.

δH (J in Hz)

1α

2.03 dd (13.5, 10.5)

1β
2
3

δC
32.6

1.85 d (14.0)

δH (J in Hz)
2.19, m

δC
31.8

1.90, m

1.84 m

33.2

1.90 m

33.0

3.83 dd (6.5, 5.5)

75.2

3.90 d (5.0)

75.7

6.11 q (1.5)

118.4

6.16 s

117.8

4
5

5

73.3

6

73.2

136.2

136.8

7

5.43 d (1.5)

75.9

5.29 d (1.5)

76.2

8

5.14 dd (11.0, 2.0)

72.5

4.82 dd (11.0, 1.5)

70.9

9

1.65 m

25.5

1.64 dd (11.0, 9.0)

25.6

10

21.7

21.6

11

1.37 dd (11.5, 9.0)

31.6

1.42 dd (11.0, 9.0)

31.3

12

5.08 dd (11.5, 3.5)

69.5

5.01 dd (11.5, 3.5)

69.5

13

2.94 qd (7.0, 3.5)

43.4

3.04 qd (7.0, 3.5)

43.2

14

207.8

207.8

15

73.2

73.0

16

0.88 d (7.0)

13.0

0.99 d (6.5)

11.0

17

2.11 d (1.5)

17.7

2.13 s

16.4

18
19α
19β

1.16 s
3.88 d (12.0)
3.62 d (12.0)

24.4
64.9

1.16 s
4.08 d (12.0)
3.60 d (12.0)

23.2
64.8

20
3OAc

0.95 d (7.0)

13.4

1.04 d (7.0)

12.3

3-OH: 5.32 d (6.5)

12OAc

170.3
2.03 s

19OAc

21.3

170.8
2.10 s

170.5
1.64 s

7-R
C=O

20.5
OAng
166.3

19.7
171.2

1.93 s

19.3
OAng
166.6

1'
2'

128.2

128.1

3'

6.89 q (7.0)

139.0

6.95 m

138.3

4'

1.79 d (7.0)

14.8

1.84 d (7.0)

13.1

5'

1.78 s

12.5

1.87 s

10.8

6'

-

-

-

OAng
166.9

8-R

O-Bz

C=O
1''

165.2
129.8

2''

7.87 dd (7.5, 1.5)

129.6

3''

7.53 dd (7.5, 7.5)

129.4

6.83 m

138.3

4''

7.66 m

134.0

1.81 d (7.5)

13.1

5''

7.53 dd (7.5, 7.5)

129.4

1.80 s

10.6

6''

7.87 dd (7.5, 1.5)

125.6

-

-

40

128.0

All compounds (1–5) were evaluated for cytotoxicity in three cell lines. B16F10
murine melanoma cells are often used for their high metastatic potential and
moreover their ability to express MDR19. Similarly, HaCat, a line of immortalized
human keratinocytes, were used to model one of the outermost layers of skin and
thus serve as a significant site of action for this Euphorbia spp. based terpenoids10.
Cell Titer Glo is a luminescence-based viability assay that utilizes luciferase and
ATP from lysed cells to generate a positive correlation between viability and
luminesce intensity. Viable cells which produce ATP will produce a higher
luminescence signal as opposed to damaged (necrotic) or dying (apoptotic) cells11.
As a cytotoxic control, etoposide, an MDR1 substrate and chemotherapeutic agent 12,
at 50 μM decreased B16F10 cell viability by 25.16%. Only compounds 2, 3, and 4
induced significant toxicity. Moreover, compound 2 had the greatest range of
toxicity from 100 μM (49.63% decrease) to 20 μM (14.69% decrease). In human
keratinocytes (HaCat), each compound caused a decrease in cell viability above 40
μM. Compounds 3 and 4 caused reductions in cell viability by approximately
12.42% and 17.92%, respectively, at a concentration of 30 μM. Compound 3 was
able to decrease viability by as much as 93.63% at 50 μM. SH-SY5Y cells are
typically used in neuropharmacology and neurodegenerative studies to model the
sensitive nature of neurons13. Specifically, undifferentiated SH-SY5Y cells serve as
an in vitro model for cancer and Parkinson’s disease due the dopaminergic receptors
available13. Exposure to etoposide at 10 μM decreased viability by approximately
44.64% (as in agreement with literature14). The compounds induced a cytotoxic
effect at concentrations at 50 μM and above.
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Figure 3. Cytotoxicity activities of 1–5.
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EXPERIMENTAL SECTION
General Experimental Procedures. The general experiments were completed
according to the reported procedures with minor modification (General
Experimental Procedures, Supporting Information).
Plant Material. Aerial parts of E. saudiarabica were collected in July 2015 in
Thahban, Asir Province, Saudi Arabia. A.A. Fayed and D.A. Al-zahrani identified
the plant species in 200715.
Extraction and Isolation. Air-dried powder of E. saudiarabica was macerated with
methanol (3 × 15 L). The filtrate was concentrated under reduced pressure to afford
a dried methanol extract (135 g). This was suspended in distilled water and
successively partitioned to yield n-hexanes (66.6 g), ethyl acetate (3.32 g), and nbutanol (13.88 g) extracts after solvent removal in vacuo. The n-hexanes extract was
dissolved in acetonitrile and successively partitioned again with n-hexanes to yield
acetonitrile extract (22.1 g). Next, acetonitrile extract was fractioned using silica gel
column eluted with n-hexanes/EtOAc (from 20:1 to 3:1) and then with
CHCl3/MeOH (from 40:1 to 1:1) to afford six major fractions (ES5–ES10). Fraction
ES8 (1.07 g) was fractionated by semi-preparative HPLC (CH3CN/H2O) to afford
two major fractions (ES8A and ES8B). Fraction ES8A (100 mg) was further purified
by C18 reversed-phase semi-preparative HPLC (CH3CN/H2O) to give compound 1
(19.1 mg). Fraction ES6 (1.28 g) was chromatographed over MCI gel column
chromatography eluting with H2O/MeOH (9:1 to 1:9) to afford four major fractions
(ES6A–ES6D). Fraction ES6C was purified by semi-preparative HPLC
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(CH3CN/H2O 45:55, 2.5 mL/min) to obtain compounds 2 (6.2 mg) and 3 (5.5 mg).
Fraction ES9 (1.3 g) afforded compounds 4 (3.5 mg) and 5 (2.6 mg) by repeated
semi-preparative HPLC (CH3CN/H2O 35:65, 2.5 mL/min).
Saudiarabicain A (1) Reddish amorphous powder; [α]20D +78 (c 0.5, MeOH);
UV (MeOH) max (log ε) 208 (5.61), 272 (4.75) nm; IR (KBr) max 2965, 1732, 1271,
1235, 1023, 989 cm−1; 1H and 13C NMR (CD3OD), see Table 1; (+)-HRESIMS m/z
633.2332 [M + Na]+ (calcd for C33H38O11Na, 633.2312).
Saudiarabicain B (2) White amorphous powder; [α]20D +78 (c 0.5, MeOH);
UV (MeOH) max (log ε) 203 (5.40), 270 (3.49) nm; IR (KBr) max 1737, 1716, 1234,
1012, 988 cm−1; 1H and

13

C NMR (CD3OD), see Table 1; (+)-HRESIMS m/z

611.2495 [M + Na]+ (calcd for C31H40O11Na, 611.2468).
Saudiarabicain C (3) White amorphous powder; [α]20D +78 (c 0.5, MeOH);
UV (MeOH) max (log ε) 210 (4.93), 270 (3.71) nm; IR (KBr) max 2965, 1732, 1245
cm−1; 1H and 13C NMR (CD3OD), see Table 1; (+)-HRESIMS m/z 691.2751 [M +
Na]+ (calcd for C36H44O12Na, 691.2730).
Saudiarabicain D (4) White amorphous powder; [α]20D +78 (c 0.5, MeOH);
UV (MeOH) max (log ε) 200 (4.56), 270 (3.20) nm; IR (KBr) max 1716, 1299, 1243,
1180 cm−1; 1H and 13C NMR (DMSO-d6), Table 2; (+)-HRESIMS m/z 675.2785 [M
+ Na]+ (calcd for C36H44O11Na, 675.2781).
Saudiarabicain E (5) White amorphous powder; [α]20D +78 (c 0.5, MeOH);
UV (MeOH) max (log ε) 222 (3.92), 275 (2.84) nm; IR (KBr) max 2958, 1344,
1241,1135 cm−1; 1H and

13

C NMR (CD3OD), see Table 2; (+)-HRESIMS m/z

653.2953 [M + Na]+ (calcd for C34H46O11Na, 653.2938).
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Cell Culture
Murine B16F10 melanoma cells and human HaCat keratinocytes were generously
donated by Dr. Wen of Providence College. Human SH-SY5Y neuroblastoma cells
were obtained from the European Collection of Authenticated Cell Cultures
(ECACC; Porton Down, England UK). Melanoma cells and keratinocytes were
maintained using DMEM supplemented with 10% fetal bovine serum (FBS) and 1%
penicillin/streptomyces antibiotic cocktail. Neuroblastoma cells were maintained
using DMEM/F12, also supplemented with 10% FBS and 1% pen/strep antibiotic
cocktail. All cells were housed in a humidified incubator set to 37 °C under 5% CO2.
Cells were counted prior to seeded onto assay plates by using a hemocytometer and
trypan blue dye. Following seeding, cells were allowed to incubate for at least 24
hours in serum-free media. Compounds were dissolved in DMSO (Sigma Aldrich,
St. Louis, MO, USA) and diluted into serum-free media whereby the final DMSO
content was less than 0.1% DMSO.
Cell Viability Assessment
Cell viability was determined using Cell Titer Glo 2.0 luminescence-based assay
(Promega, Madison, WI, USA). As previously reported by our group16, cells were
seeded on white-walled 96-well plates at a density of either 100,000 cells/mL
(B16F10 and SH-SY5Y) or 200,000 cells/mL (HaCat) to yield an 85% confluent
plate following 24 hours. In brief, cells were treated with test compounds at 100, 50,
40, 30, 20, and 10 μM for 24 hours. Cell Titer Glo Reagent was then added directly
to each well, mixed on an orbital shaker for approximately 2 minutes, and allowed
to incubate at room temperature for 10 minutes prior to measuring luminescence
using a Glomax Luminometer (Promega, Madison, WI, USA).
45

Statistical Analysis
Data are reported as mean ± standard error where each experiment was performed
in triplicate. Statistical analysis was performed using Graphpad Prism Software (La
Jolla, CA, USA) and significance was determined using one-way analysis of
variance (ANOVA) using Dunnett’s Correction for multiple comparisons.
Calculated P values were determined to be as follows: P< 0.05*, P< 0.01**,
P<0.001***, P<0.0001****.
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ABSTRACT
The dried methanolic extract of aerial parts of Euphorbia saudiarabica was
subjected to investigate its flavonoid composition using LC-ESI-TOF-MS/MS. In
the present study, 36 flavonoids were identified. The compounds constituted 7
flavonoids based on the galangin aglycon, 9 flavonoids based on the apigenin
aglycon, and 20 flavonoids originated from luteolin. Among these, 3 compounds are
malonyl substituted, and 13 compounds are acetyl substituted.
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INTRODUCTION
Flavonoids and their conjugate forms are some of the most abundant
polyphenols, and more than 8000 different flavonoids have been demonstrated so
far. These flavonoids are considered to be the most plentiful natural products in the
human diet since they are found in many plant tissues, including fruits and
vegetables. In addition, the presence of flavonoids among plant genera, such as
Euphorbia genus, are widely described. A literature review of the Euphorbia genus
showed that many of its secondary metabolites, like diterpenoids and flavonoids, are
highly bioactive [1]. Euphorbia saudiarabica is one of about 8000 species of the
family Euphorbiaceae [2]. It is an endemic species to the southwest of Saudi Arabia
close to the Red Sea [3]. This plant, like other Euphorbia species, is known for its a
milky skin-irritant latex.
To our knowledge, the flavonoid content of E. saudiarabica have not been
studied. Therefore, the objective of the present study was to determine the
phytochemical profiles of the total flavonoid contents of this plant using the liquid
chromatography-tandem mass spectrometry (LC-MS/MS) technique.
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MATERIALS AND METHODS
Chemicals
LC-MS grade methanol was purchased from Sigma-Aldrich (St. Louis, MO, USA).

Sample preparation
Air-dried powder of E. saudiarabica (1 g) was macerated with methanol (3 × 15
mL). The filtrate was concentrated under reduced pressure to afford a dried methanol
extract. The methanol extract was re-dissolved in 10 mL acetonitrile, then
partitioned with hexane (3 × 10 mL). The acetonitrile layer was concentrated under
reduced pressure and re-dissolved in methanol. The methanol solution was stored at
−20 °C and filtered (0.22 μm) before analysis.

Liquid Chromatography-Mass Spectrometry Conditions
LC-ESI-TOF-MS/MS analyses were performed on a SHIMADZU Prominence
UFLC system (Marlborough, MA, USA) consisting of two LC-20AD pumps, a
DGU-20A degassing unit, a SIL-20AC auto sampler, a CTO-20AC column oven,
and a CBM-20A communication bus module. Chromatographic separation was
performed on a 150 mm × 4.6 mm i.d., 3 μm, Atlantis dC18 column (Waters,
Milford, MA, USA). The mobile phase consisted of 0.1% formic acid/methanol (A)
and 0.1% aqueous formic acid (B) with a gradient elution of 5% A from 0 to 5 min,
5%–95% A from 5 to 95 min. The column temperature was 40 °C, the flow rate was
0.50 mL/min, and the injection volume was 10 μL. Mass spectrometry was
performed using a Triple TOF 4600 system from Applied Biosystems/MDS Sciex
(Framingham, MA, USA) coupled with ESI interface. Nitrogen was used in all
cases. In this study, the parameters were optimized as follows: ESI voltage, −4500
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V; GS1, 40 psi; GS2, 55 psi; CUR, 30 psi; turbo gas temperature, 550 °C;
declustering potential, −80 V; collision energy, 40 eV. Instrument calibration was
carried out according to the manufacturer’s instructions. The mass range was set
from m/z 100 to 1250. The data were acquired and processed using Analyst TF 1.7
Software.
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RESULTS AND DISCUSSION
Qualitative characterization of the flavonoids present in the methanol extract of
aerial parts of E. saudiarabica was performed in ESI negative ionization mode, and
all of the compounds showed [M − H]– ions (Table 1). Accurate mass data were then
acquired in full scan analysis, and product ion mass data were acquired via the
information dependent acquisition (IDA) method. An Atlantis dC18 column was
used, and formic acid was introduced into the mobile phase (0.1%) to alleviate peak
tailing and to produce better peak shapes. The acidic conditions did not significantly
affect the ionization efficiency of the compounds in negative mode.
In the present study, 36 flavonoids were identified based on previously reported
MS/MS fragmentation patterns for flavonoids [4]. The compounds constituted 7
flavonoids based on the galangin aglycon, 9 flavonoids based on the apigenin
aglycon, and 20 flavonoids originated from luteolin (Table 1). Among these, 3
compounds are malonyl substituted, and 13 compounds are acetyl substituted. The
total ion chromatograms profiles of the compounds are shown in Figure. 1. Accurate
mass measurements, retention times (tR), formula, errors, and main MS/MS product
ions for all of the flavonoids are summarized in Table 1.
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Figure 1. Total ion chromatogram of a methanol extract from aerial parts of E.
saudiarabica.

Figure 2. The skeletal structure of galangin, apigenin, and luteolin.
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Table 1. LC-ESI-TOF-MS/MS data for flavonoids identified in a methanol extract
from aerial parts of E. saudiarabica.
No.

1

tR

Molecular

(min)

formula

41.27

C33H38O21

HR-ESI(-)-MS
[M-H]-

(m/z)

769.1844

Error

Major and important MS/MS

(ppm)

ions

1.4528

607, 431, 337, 311, 269, 175,
151, 149, 113

Identification

A-(GlcUA-Hex,
Hex)

2

45.15

C28H30O16

609.1460

-0.1789

447, 285, 199, 175, 151, 133

L-(Hex, Hex)

3

46.95

C27H28O17

623.1272

2.9311

605, 561, 447, 357, 337, 327,

L-(Hex, GlcUA)

285, 199, 175, 151, 133
4

47.53

C28H30O16

609.1487

4.2535

447, 285, 199, 175, 151, 133

L-(Hex-Hex)

5

48.32

C27H28O17

623.1273

3.0916

447, 285, 199, 175, 151, 133

L-(Hex-GlcUA)

6

48.67

C28H30O16

609.1476

2.4477

447, 357, 327, 285, 199, 175,

L-(Hex-Hex)

151, 133
7

50.12

C27H28O16

607.1313

1.3853

431, 337, 315, 269, 225, 151,

A-(Hex-GlcUA)

149, 117, 113, 107
8

51.18

C21H20O11

447.0942

2.0457

357, 327, 285, 199, 175, 151,

L-Hex

133
9

51.47

C28H30O17

637.1434

3.7297

619, 461, 337, 299, 284, 199,
175, 151, 133

ML-(HexGlcUA)

10

51.77

C28H30O16

609.1487

4.2535

447, 285, 199, 175, 151, 133

L-(Hex-Hex)

11

51.86

C27H30O15

593.1525

2.2012

431, 269, 225, 151, 149, 117,

A-(Hex-Hex)

113, 107
12

52.08

C28H30O17

637.1429

2.9449

461, 299, 284, 199, 175, 151,
133

13

52.25

C27H28O16

607.1312

1.2206

431, 357, 337, 269, 225, 151,

ML-(HexGlcUA)
A-(Hex-GlcUA)

149, 117, 113, 107
14

15

52.67

54.03

C29H30O17

C28H30O16

649.1418

621.1471

1.196

0.991

473, 269, 225, 151, 149, 117,
113, 107

GlcUA)

431, 269, 225, 201, 183, 181,

A-(Hex-

151, 149, 117, 113
16

54.07

C24H22O14

533.0937

0.0386

A-(acetylHex-

489, 285, 199, 175, 151, 133

MethylGlcUA)
L-(6malonylHex)

17

18

54.20

54.36

C30H30O20

C23H22O12

709.1279

489.1058

3.0071

3.9866

665, 623, 603, 489, 447, 379,

L-(malonylHex,

357, 285, 199, 175, 151, 133

GlcUA)

447, 429, 357, 327, 285, 256,

L-acetylHex

227, 199, 175, 151, 133
19

54.72

C21H20O10

431.0976

-1.7878

56

269, 268, 240, 211, 151, 117

G-3-O-Hex

20

56.02

C21H20O10

431.0990

1.4596

269, 268, 240, 211, 151, 117

21

56.41

C21H20O11

447.0934

0.2563

285, 199, 175, 151, 133

22

56.96

C24H22O14

533.0949

2.2896

489, 447, 285, 199, 175, 151,

G-3-O-Hex
L-Hex
L-malonylHex

133
23

56.99

C23H22O12

489.1041

0.5109

447, 357, 327, 285, 256, 227,

L-acetylHex

199, 175, 151, 133
24

57.15

C29H30O17

649.1408

-0.3444

473, 269, 225, 151, 149, 117,
113, 107

A-(acetylHexGlcUA)

25

57.70

C23H22O11

473.1095

1.1932

269, 268, 240, 211, 151, 117

G-3-O-acetylHex

26

58.38

C23H22O11

473.1088

-0.2863

269, 268, 240, 211, 151, 117

G-3-O-acetylHex

27

58.59

C21H20O11

447.0937

0.9273

285, 199, 175, 151, 133

28

59.02

C23H22O11

473.1092

0.5591

269, 268, 240, 211, 151, 117

G-3-O-acetylHex

29

59.39

C29H30O18

665.1350

-1.4106

489, 357, 327, 285, 199, 175,

L-(acetylHex-

151, 133

L-Hex

GlcUA)

30

60.47

C23H22O11

473.1096

1.4046

269, 268, 240, 211, 151, 117

G-3-O-acetylHex

31

61.79

C23H22O12

489.1044

1.1243

447, 357, 327, 285, 256, 227,

L-acetylHex

199, 175, 151, 133
32

62.20

C29H30O17

649.1419

1.35

473, 269, 225, 151, 149, 117,
113, 107

A-(acetylHexGlcUA)

33

63.10

C15H10O6

285.0401

-1.2692

199, 175, 151, 133

34

64.42

C23H22O12

489.1044

1.1243

285, 199, 175, 151, 133

L-(6-acetylHex)

35

65.25

C23H22O11

473.1096

1.4046

269, 268, 240, 211, 151, 117

G-3-O-acetylHex

36

67.36

C15H10O5

269.0460

1.6832

227, 225, 201, 197, 183, 181,

A

159, 151, 149, 117, 107
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Compounds 19 (tR=54.72 min) and 20 (tR=56.02 min) displayed same [M − H]−
at m/z 431, and their MS/MS fragmentation all yielded the aglycone Y0− ion at m/z
269. This aglycone was further confirmed as galangin by the characteristic product
ions at m/z 117, 151, 211, and 240 [4]. The product ion at m/z 269 [M − H − 162]−
also indicated the loss of a hexose group (162 Da). However, the nature of hexose
could not be determined only by MS data. Therefore, compounds 19 and 20 were
identified as galangin-O-hexosides. In their MS/MS spectrum, [Y0 − H]− ion at m/z
268 with high intensity was also observed. Flavonols substituted at the 3-OH
position should yield a high-intensity fragment [Y0 − H]−, sometimes higher than the
Y0− ion [5]. Thus, the glycosylation position of compounds 19 and 20 should be at
3-OH. Therefore, compound 19 and 20 were further identified as galangin-3-Ohexosides.
Compounds 25, 26, 28, 30 and 35 all produced the same [M − H]− ion at m/z
473 with different tR of 57.70, 58.38, 59.02, 60.47, and 65.25 min, respectively. In
their MS/MS spectra, they all showed the same fragment ion at m/z 269 which was
produced by the loss of an acetyl-hexose group (204 Da). Also, the characteristic
fragment ions of galangin at m/z 117, 151, 211, and 240 were observed. Thus, these
compounds were identified as galangin-O-(acetyl-hexoside). High-intensity radical
aglycone [Y0 − H]− ion at m/z 268 was found in the MS/MS spectra of all compounds,
indicating that they were galangin-3-O-(acetyl-hexoside).
Compound 36 (tR=67.36 min) produced the [M − H]− ions at m/z 269. In the
MS/MS spectrum, the typical product ions at m/z 107, 117, 149, 151, and 225 led to
the identification of compound 36 as apigenin [6]. Compound 11 (tR=51.86 min)
displayed a pseudomolecule ion [M − H]− at m/z 593 and gave the aglycone Y0− ion
at m/z 269 in its MS/MS spectrum. The typical product ions at m/z 107, 117, 149,
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151, and 225 led to the identification of the aglycone as apigenin. The loss of 324
Da could be attributed to the loss of a caffeoyl-hexose unit or a di-hexose unit. It
should be noted that deprotonated apigenin-O-caffeoylhexoside possesses the same
nominal molecular weight of 593 as deprotonated apigenin-O-hexosylhexoside, but
their accurate molecular weights are different, i.e., 593.1300 for apigenin-Ocaffeoylhexoside and 593.1511 for apigenin-O-hexosylhexoside, and their
molecular formulae are C30H26O13 and C27H30O15, respectively. According to the
deprotonated molecular ion [M − H]− at m/z 593.1525 measured by TOF-MS,
compound 11 was identified as apigenin-O-hexosylhexoside.
Compounds 7 (tR=50.12 min) and 13 (tR=52.25 min) produced the same [M −
H]− ions at m/z 607. In their MS/MS spectra, they showed a same aglycone Y0− ion
at m/z 269. In addition, the aglycone was determined as apigenin by the characteristic
fragment ions at m/z 107, 117, 149, 151, and 225. A weak ion at m/z 431 arising from
the loss of 176 Da was also observed in their MS/MS spectrum, which represents a
loss of a glycuronic acid unit. Further loss of 162 Da ([M − H − glycuronic acid unit
− hexose unit]−) allowed us to infer that compounds 7 and 13 may consist of the
apigenin moiety with a glycuronic acid group (176 Da) and a hexose group (162
Da), while the glycuronic acid group is in the external position. Thus, compounds 7
and 13 were identified as apigenin-O-hexosylglycuronides.
Compounds 14 (tR=52.67 min), 24 (tR=57.15 min), and 32 (62.20 min) all
produced the same [M − H]− ions at m/z 649. In their MS2 spectra, they all showed
the same aglycone Y0− ions at m/z 269. In addition, the characteristic fragment ions
of apigenin at m/z 107, 117, 149, 151, and 225 were observed. The weak ions at m/z
473 in their MS/MS spectrum indicated that compounds 14, 24, and 32 contained a
glycuronic acid group (176 Da) and an acetyl-hexose group (204 Da), while the
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glycuronic acid group is in the external position. Thus, compounds 14, 24, and 32
were identified as apigenin-O-acetylhexosylglycuronides.
Compounds 15 (tR=54.03 min) displayed its [M − H]− ions at m/z 621. In the
MS/MS spectra, the aglycone Y0− ion at m/z 269 was observed and was identified as
apigenin by the characteristic fragment ions at m/z 107, 117, 149, 151, and 225. A
weak ion at m/z 431 indicated a loss of a methyl-glycuronic acid unit (190 Da).
Compound 15 was identified as apigenin-O-(hexosyl-methylglycuronide).
Compounds 1 (tR=41.27 min) produced the [M − H]− ions at m/z 769. In the
MS/MS spectra, it gave the aglycone Y0− ion at m/z 269. In addition, the aglycone
was determined as apigenin by the characteristic fragment ions at m/z 107, 117, 149,
151, and 225. The loss of 500 Da allowed us to infer that compound 1 may consist
of the apigenin moiety with a glycuronic acid group (176 Da) and two hexose groups
(162 Da). The high-intensity ion at m/z 431 indicated a hexose group and a hexoseglycuronic acid group glycosylated to two different positions on the apigenin moiety
of compound 1. The weak ions at m/z 607 arising from the loss of 162 Da was also
observed in MS/MS spectrum, which represents the hexose as in the external
position of the hexose-glycuronic acid group. Thus, compound 1 was identified as
apigenin-O-(hexoside, glucuronylhexoside).
Compound 33 (tR=63.10 min) produced the [M − H]− ions at m/z 285. In the
MS/MS sepectrum, the typical product ions at m/z 133, 151, 175, and 199 led to the
identification of compound 33 was luteolin [4]. Compounds 8 (tR=51.18 min), 21
(tR=56.41 min), and (27) (tR=58.59 min) displayed the same [M − H]− ions at m/z
447, and their MS/MS spectrum all yielded the aglycone Y0− ion at m/z 285. This
aglycone was further confirmed as luteolin by the characteristic product ions at m/z
133, 151, 175, and 199. The product ion at m/z 285 [M − H − 162]− also indicated
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the loss of a hexose group (162 Da). Therefore, compounds 8, 21, and 27 were
identified as luteolin-O-hexosides.
Compounds 18 (tR=54.36 min), 23 (tR=56.99 min), 31 (tR=61.79 min), and 34
(tR=64.42 min) all produced the same [M − H]− ions at m/z 489. In their MS/MS
spectra, they all showed the same aglycone Y0− ions at m/z 285. In addition, the
characteristic fragment ions of luteolin at m/z 133, 151, 175, and 199 were observed.
The loss of 204 Da indicated the existence of an acetyl hexose group in each
compound. Thus, compounds 18, 23, 31, and 34 were identified as luteolin-Oacetylhexosides. In the MS/MS spectrum, compounds 18, 23, and 31 gave the same
weak ion at m/z 447 that indicated the loss of acetyl group. However, the ion at m/z
447 was not observed in the MS/MS spectrum of compound 34. The acylation in
position 6 of hexose is difficult to break in mass spectrometry [7]. Thus, compound
34 was further identified as luteolin-O-(6-acetylhexoside).
Compounds 16 (tR=54.07 min) and 22 (tR=56.96 min) produced the [M − H]−
ions at m/z 533. In the MS/MS spectra, they all gave aglycone Y0− ions at m/z 285.
In addition, the aglycone was determined as luteolin by the characteristic fragment
ions at m/z 133, 151, 175, and 199. Their product ions at m/z 489 and 285 by the loss
of 44 Da (CO2) and 204 Da (acetyl-hexose group) indicated the existence of a
malonyl-hexose group [7]. Therefore, compounds 16 and 22 were identified as
luteolin-O-(malonylhexoside). In the MS/MS spectrum, compound 22 gave a weak
ion at m/z 447, indicating the loss of an acetyl group (remains of malonyl after
decarboxylation) from an ion at m/z 489. However, the ion at m/z 447 was not
observed in the MS/MS spectrum of compound 16. Therefore, compound 16 was
further identified as luteolin-O-(6-malonylhexoside).
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Compounds 2 (tR=45.15 min), 4 (tR=47.53 min), 6 (tR=48.67 min), and 10
(tR=51.77 min) displayed the same pseudomolecule ions [M − H]− at m/z 609. The
aglycone Y0− ion at m/z 285 and typical product ions at m/z 133, 151, 175, and 199
in their MS/MS spectrum indicated the aglycone as luteolin. The loss of 324 Da
could be attributed to the loss of a caffeoyl-hexose unit or a di-hexose unit. Their
accurate molecular weights by TOF-MS supported their molecular formulae to be
C28H30O16. Thus, compounds 2, 4,6, and 10 consist of the luteolin moiety with two
hexose groups (162 Da). In the MS/MS spectrum of compound 2, the high-intensity
product ion at m/z 447 indicated the two hexose groups substituted for different
positions on the luteolin moiety. However, only the tiny peak of an ion at m/z 447
was observed in the MS/MS spectrum of compounds 4, 6, and 10. Therefore,
compounds 4, 6, and 10 were determined as luteolin-O-hexosylhexosides, and
compound 2 was identified as luteolin-O-(hexoside, hexoside).
Compounds 3 (tR=46.95 min) and 5 (tR=48.32 min) exhibited the same [M −
H]− ions at m/z 623. In their MS/MS spectra, the Y0− ions at m/z 285 and the
characteristic fragment ions at m/z 133, 151, 175, and 199 were observed, suggested
the aglycone was luteolin. The loss of 338 Da indicated ccompounds 3 and 5 consist
of the luteolin moiety with a hexose group (162 Da) and a glucuronic acid group
(176 Da). In the MS/MS spectrum of compound 3, a high-intensity product ion at
m/z 447 was observed, indicating the hexose and glucuronic acid groups substituted
to different positions on the luteolin moiety. In the MS/MS spectrum of compound
5, only a weak ion at m/z 447 arising from the loss of 176 Da was observed,
indicating the existence of the hexose-glucuronic acid group and glucuronic acid in
the external position. Thus, compounds 3 and 5 were identified as luteolin-O(hexoside, glucuronide) and luteolin-O-hexosylglucuronide, respectively.
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Compounds 9 (tR=51.47 min) and 12 (tR=52.08 min) gave the same [M − H]−
ions at m/z 637. In the MS/MS spectra, they gave the aglycone Y0− ion at m/z 299.
In addition, the aglycone was determined as methylluteolin by the characteristic
fragment ions at m/z 133, 151, 175, 199, and 284. The loss of 338 Da suggested
compounds 9 and 12 consist of the methylluteolin moiety with a glucuronic acid
group (176 Da) and a hexose group (162 Da). In their MS/MS spectrum, the weak
ions at m/z 461 arising from the loss of 176 Da were observed, representing
glucuronic acid in the external position of the hexose-glucuronic acid group. Thus,
compounds 9 and 12 were identified as methylluteolin-O-hexosylglucuronide.
Compounds 29 (tR=59.39 min) and 17 (tR=54.20 min) gave [M − H]− ions at m/z
665 and 709. The aglycone Y0− ion at m/z 285 was observed in both compounds, and
the aglycone was identified as luteolin by MS/MS spectrum. The weak ion at m/z
489 ([M − H − glucuronic acid group]−) combined with the Y0− ion at m/z 285 ([M
− H − 176 Da − 204 Da]−) suggested compound 29 possessed an acetylhexoseglucuronic acid group and glucuronic acid was in the external position. Thus,
compound 29 was identified as luteolin-O-acetylhexosylglucuronide. In the MS/MS
spectrum of compound 17, product ions of m/z 665 ([M − H − 44 Da]−) and m/z 623
([M − H − 44 Da − 42 Da]−) indicated the existence of a malonyl group. The high
intensity product ions of m/z 489 ([M − H − 44 Da − 176 Da]−) and 285 ([M − H −
176 Da − 44 Da − 204 Da]−) indicated that a glucuronic acid group and a
malonylhexose group substituted to different positions of luteolin. Thus, compound
17 was identified as luteolin-O-(malonylhexoside, glucuronide).
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CONCLUDING REMARKS
In summary, a rapid and reliable method employing LC-ESI-TOF-MS/MS was
developed for the identification of flavonoids aerial parts of E. saudiarabica. Based
on accurate mass measurement and characteristic fragmentation ions, 36 flavonoids,
including 7 flavonoids originating from galangin, 9 from apigenin, and 20 from
luteolin, were identified. Among these, 3 compounds are malonyl substituted and 13
compounds are acetyl substituted. The LC-ESI-TOF-MS/MS method established
herein could be used for future characterization and standardization of E.
saudiarabica.
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Conclusion and Future Plan

The aim of this work was the isolation and structure elucidation of the secondary
metabolites from the crude extract of two plants: silver maple leaves (Acer
saccharinum) and aerial parts of the species Euphorbia saudiarabica. First, the
polyphenolic contents of the silver maple leaves were investigated by using TLC,
RP-HPLC, and the Folin-Ciocalteau method for quantifying total polyphenols. Next,
the isolation and purification process was carried out which led to 10 identified
compounds by means of spectroscopic methods (NMR, and HPLC-DAD). These
compounds, including six GCGs (ginnalins A-C [1-3], maplexins B, D, and F [4-6]),
methyl syringate (7), methyl gallate (8), and 3-methoxy-4-hydroxyphenol-1-β-D-(6galloyl)-glucopyranoside (9). Additionally, one sesquiterpenoid, namely, pubineroid
A (10), was isolated and identified. Likewise, the diterpenoids contents of
Euphorbia saudiarabica were investigated using HPLC-DAD and TLC techniques.
Next, after multistep of the separation and purification, five new lathyranediterpenoid compounds were elucidated. Additionally, the cytotoxicity effects of
these compounds were evaluated; all of them exhibited mild to moderate
cytotoxicity effects. Next, a rapid and reliable method employing LC-ESI-TOFMS/MS was developed for the identification of flavonoids from the aerial parts of
E. saudiarabica which led to 36 reported flavonoid compounds. Finally, future plan
will be focused on exploring the biological activities of the isolated diterpenoids (15) from Euphorbia saudiarabica, mainly for their multi-drug resistance (MDR)
inhibitory effects. In addition, future goals will be focused on investigating other
Euphorbia species endemic to Saudi Arabia to evaluate their cytotoxicity, as well as
their antifungal and MDR-modulatory effects.
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Figure S1. Structures of the isolated compounds (1-5) .
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Figure S2. Key HMBC correlations of compounds (1-5)
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Figure S3. Key NOESY correlations of compounds (1-5)
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no.

δH (J in Hz)

δC

1α

2.56 dd (15.0, 9.0)

34.1

1β

1.67 d (15.0)

2

2.34 m

29.2

3

5.03 d (8.4)

77.1

5.70 s

116.7

4
5

73.3

6

142.1

7

5.45 brs

77.2

8

5.02 dd (11.2, 1.2)

70.2

9

1.61 dd (10.8, 9.0)

27.2

10

33.0

11

1.34 dd (8.7, 1.5)

31.0

12

4.65 dd (4.5, 1.5)

78.1

13

3.34 qd (6.6, 4.5)

48.7

14

206.4

15

72.9

16

0.84 d (7.2)

16.0

17

2.08 s

16.6

18

1.25 s

17.0

19

6.13 s

103.1

20

0.96 d (6.6)

6.8

3-OAc

170.5
1.99 s

8-OAc

19.1
170.6

1.87 s

19.5

12-OAc
19-OAc

170.8
2.01 s

19.9

7-R

O-Bz

C=O

170.5

1'

129.5

2'

7.99 m

129.3

3'

7.42 ddd (7.2, 7.2, 1)

128.5

4'

7.55 dddd (7.5, 7.5, 1.5, 1.5)

133.3

5'

7.42 ddd (7.2, 7.2, 1.5)

128.5

6'

7.99 m

129.3

7'

-

-

Table S1. 1H and 13C NMR Spectroscopic Data of compound 1
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no.

δH (J in Hz)

δC

1α

2.59 dd (14.7, 9.0)

34.1

1β

1.72 d (15.0)

2

2.36 m

29.3

3

5.06 d (8.4)

77.1

5.53 s

116.4

4
5

73.3

6

142.4

7

5.22 brs

77.1

8

4.92 d (11.1)

70.2

9

1.46 dd (10.8, 9.0)

27.2

10
11

32.7
1.25 m

30.9

12

4.58 d (4.8)

78.0

13

3.30 qd (6.9, 5.1)

48.7

14

206.4

15

72.9

16

0.84 d (7.5)

16.0

17

1.97 d (1.8)

16.5

18

1.20 s

17.0

19

6.03 s

103.0

20

0.93 d 6.6

6.8

3-OAc

170.5
1.97 s

8-OAc

19.0
170.7

1.98 s

19.9

12-OAc
19-OAc

170.6
1.84 s

19.5

7-R

O-Ang

C=O

166.5

1'
2'

128.0

3'

6.86 q (6.6)

138.4

4'

1.74 d (6.6)

13.2

5'

1.76 s

10.8

6'

-

-

7'

-

-

Table S2. 1H and 13C NMR Spectroscopic Data of compound 2

75

no.

δH (J in Hz)

δC

1α

2.70 dd (14.7, 9.0)

31.1

1β

1.60 d (14.7)

2

2.41 m

29.3

3

5.13 d (8.7)

76.8

4
5

71.0
5.43 m

6

117.6
138.7

7

5.04 d (1.8)

76.4

8

4.54 dd (10.8, 1.8)

70.7

9

1.30 dd (10.8, 9.0)

25.0

10

21.6

11

1.15 dd (11.1, 9.0)

30.9

12

4.84 dd (11.1, 7.8)

69.4

13

2.82 dq (7.5, 7.2)

43.0

14

207.0

15

73.4

16

0.84 d (7.5)

15.9

17

1.96 d (1.5)

16.2

18

1.00 s

23.2

19

19α: 4.01 d (12.0)
19β: 3.46 d (12.0)
0.92 d (7.2)

64.7

20
3-OAc

12.4
170.6

2.00 s
8-OAc

19.7
170.4

1.94 s
12-OAc
1.89 s
19-OAc
1.88 s

19.0
170.8
19.33
171.3
19.5

7-R

O-Bzl

C=O

170.5

1'

134.1

2'

129.1

3'

7.20 5H m

126.8

4'

128.2

5'

126.8

6'
7'

129.1
3.65 s

40.7

Table S3. 1H and 13C NMR Spectroscopic Data of compound 3
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no.

δH (J in Hz)

δC

1α

2.03 dd (13.5, 10.5)

32.6

1β

1.85 d (14.0)

2

1.84 m

33.2

3

3.83 dd (6.5, 5.5)

75.2

6.11 q (1.5)

118.4

4
5

73.3

6

136.2

7

5.43 d (1.5)

75.9

8

5.14 dd (11.0, 2.0)

72.5

9

1.65 m

25.5

10

21.7

11

1.37 dd (11.5, 9.0)

31.6

12

5.08 dd (11.5, 3.5)

69.5

13

2.94 qd (7.0, 3.5)

43.4

14

207.8

15

73.2

16

0.88 d (7.0)

13.0

17

2.11 d (1.5)

17.7

18

1.16 s

24.4

19α
19β
20

3.88 d (12.0)
3.62 d (12.0)
0.95 d (7.0)

64.9

3-OAc

3-OH: 5.32 d (6.5)

13.4

12-OAc
2.03 s

170.3
21.3
170.5

1.64 s

20.5

19- OAc

7-R

O-Ang

C=O

166.3

1'
2'

128.2

3'

6.89 q (7.0)

139.0

4'

1.79 d (7.0)

14.8

5'

1.78 s

12.5

6'

-

-

8-R

O-Bz

C=O
1''
2''

7.87 dd (7.5, 1.5)

165.2
129.8
129.6

3''

7.53 dd (7.5, 7.5)

129.4

4''

7.66 m

134.0

5''

7.53 dd (7.5, 7.5)

129.4

6''

7.87 dd (7.5, 1.5)

125.6

Table S4. 1H and 13C NMR Spectroscopic Data of compound 4
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no.

δH (J in Hz)

δC

1α

2.19, m

31.8

1β

1.90, m

2

1.90 m

33.0

3

3.90 d (5.0)

75.7

6.16 s

117.8

4

73.2

5
6

136.8

7

5.29 d (1.5)

76.2

8

4.82 dd (11.0, 1.5)

70.9

9

1.64 dd (11.0, 9.0)

25.6

10

21.6

11

1.42 dd (11.0, 9.0)

31.3

12

5.01 dd (11.5, 3.5)

69.5

13

3.04 qd (7.0, 3.5)

43.2

14

207.8

15

73.0

16

0.99 d (6.5)

11.0

17

2.13 s

16.4

18

1.16 s

23.2

19α
19β
20

4.08 d (12.0)
3.60 d (12.0)
1.04 d (7.0)

64.8
12.3

3-OAc

12-OAc
2.10 s

170.8
19.7
171.2

1.93 s

19.3

19- OAc

7-R

O-Ang

C=O

166.6

1'
2'

128.1

3'

6.95 m

138.3

4'

1.84 d (7.0)

13.1

5'

1.87 s

10.8

6'

-

-

8-R

O-Ang

C=O
1''
2''

166.9
128.0

3''

6.83 m

138.3

4''

1.81 d (7.5)

13.1

5''

1.80 s

10.6

6''

-

-

Table S5. 1H and 13C NMR Spectroscopic Data of compound 5
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Figure S4. 1H NMR (300 and 75 MHz, CD3OD) spectra of 1

79

Figure S5. 13C NMR (300 and 75 MHz, CD3OD) spectra of 1

80

Figure S6. 1H-1H COSY (300 and 75 MHz, CD3OD) spectra of 1

81

Figure S7. HSQC (300 and 75 MHz, CD3OD) spectra of 1

82

Figure S8. HMBC (300 and 75 MHz, CD3OD) spectra of 1

83

Figure S9. 13C DEPT (300 and 75 MHz, CD3OD) spectra of 1

84

Figure S10. NOESY (300 and 75 MHz, CD3OD) spectra of 1

85

(+)-HRESIMS m/z 633.2332 [M + Na]+ (calcd for C33H38O11Na,
633.2312).

Figure S11. HRESI (+) MS spectra of 1

86

IR (KBr) max 2965, 1732, 1271, 1235, 1023, 989 cm-1

Figure S12. IR spectra of 1

87

Figure S13. 1H NMR (300 and 75 MHz, CD3OD) spectra of 2

88

Figure S14. 13C NMR (300 and 75 MHz, CD3OD) spectra of 2

89

Figure S15. 1H-1H COSY (300 and 75 MHz, CD3OD) spectra of 2

90

Figure S16. HSQC (300 and 75 MHz, CD3OD) spectra of 2

91

Figure S17. HMBC (300 and 75 MHz, CD3OD) spectra of 2

92

Figure S18. 13C DEPT (300 and 75 MHz, CD3OD) spectra of 2

93

Figure S19. NOESY (300 and 75 MHz, CD3OD) spectra of 2

94

(+)-HRESIMS m/z 611.2495 [M + Na]+ (calcd for C31H40O11Na,
611.2468).

Figure S20. HRESI (+) MS spectra of 2

95

IR (KBr) max 1737, 1716, 1234, 1012, 988 cm-1

Figure S21. IR spectra of 2

96

Figure S22. 1H NMR (300 and 75 MHz, CD3OD) spectra of 3

97

Figure S23.13C NMR (300 and 75 MHz, CD3OD) spectra of 3

98

Figure S24. 1H-1H COSY (300 and 75 MHz, CD3OD) spectra of 3

99

Figure S25. HSQC (300 and 75 MHz, CD3OD) spectra of 3

100

Figure S26. HMBC (300 and 75 MHz, CD3OD) spectra of 3

101

Figure S27. NOESY (300 and 75 MHz, CD3OD) spectra of 3

102

(+)-HRESIMS m/z 691.2751 [M + Na]+ (calcd for C36H44O12Na, 691.2730).

Figure S28. HRESI (+) MS spectra of 3

103

IR (KBr) max 2965, 1732, 1245 cm-1

Figure S29. IR spectra of 3

104

Figure S30. 1H NMR (500 and 125 MHz, DMSO-d6) spectra of 4

105

Figure S31. 13C NMR (500 and 125 MHz, DMSO-d6) spectra of 4

106

Figure S32. 1H-1H COSY (500 and 125 MHz, DMSO-d6) spectra of 4

107

Figure S33. HSQC (500 and 125 MHz, DMSO-d6) spectra of 4

108

Figure S34. HMBC (500 and 125 MHz, DMSO-d6) spectra of 4

109

Figure S35. NOESY (500 and 125 MHz, DMSO-d6) spectra of 4

110

(+)-HRESIMS m/z 675.2785 [M + Na]+ (calcd for C36H44O11Na,
675.2781).

Figure S36. HRESI (+) MS spectra of 4

111

IR (KBr) max 1716, 1299, 1243, 1180 cm-1

Figure S37. IR spectra of 4

112

Figure S38. 1H NMR (500 and 125 MHz, CD3OD) spectra of 5

113

Figure S39. 13C NMR (500 and 125 MHz, CD3OD) spectra of 5

114

Figure S40. 1H-1H COSY (500 and 125 MHz, CD3OD) spectra of 5

115

Figure S41. HSQC (500 and 125 MHz, CD3OD) spectra of 5

116

Figure S42. HMBC (500 and 125 MHz, CD3OD) spectra of 5

117

Figure S43. NOESY (500 and 125 MHz, CD3OD) spectra of 5

118

(+)-HRESIMS m/z 653.2953 [M + Na]+ (calcd for C34H46O11Na, 653.2938).

Figure S44. HRESI (+) MS spectra of 5

119

IR (KBr) max 2958, 1344, 1241,1135 cm-

Figure S45. IR spectra of 5
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Figure S46. The experimental ECD spectrum of 1
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Figure S47. The experimental ECD spectrum of 3
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Label

Polyphenols %

Methanol Extraction
n-Hexanes Fraction

39.0
7.8

Ethyl Acetate Fraction

58.8

Butanol Fraction

32.7

Table S6. Polyphenol content assay of silver maple fractions.

Cmpds Chemical name
1
Ginnalin A
2
Ginnalin B
3
Ginnalin C
4
Maplexin B
5
Maplexin D
6
Maplexin F
7
methyl gallate
8
methyl syringate
9
3-methoxy-4-hydroxyphenol 1-O-β-D-(6’-Ogalloyl)-glucopyranoside
10
pubinernoid A

UV (nm)
215, 276
217, 272
215, 276
215, 276
215, 278
217, 278
224, 275
217 (s), 278
215, 277

Table S7. Compounds (1-10) retention time (Rt).
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220

Figure S48. Extraction and isolation scheme of compounds 1, 7 and 10 from silver
maple leaves (Acer saccharinum).
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Figure S49. Chemical Structures of compounds 1-10 isolated from silver maple
leaves.
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Figure S50. HPLC-DAD chromatogram of ethyl acetate extract of silver maple
leaves showing the isolated compounds (1-10).
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Figure S51. The 1H NMR spectrum of compound 10

Figure S52. The 13C NMR spectrum of compound 10
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Compound
#

Absorption

MW

loge

Wavelengh

0.8053

Concentrsation
(ug/mL)
1.2

610

5.61

208

0.7422

8

610

4.75

272

0.5312

1.25

588

5.40

203

0.5206

100

588

3.49

270

0.6443

5

668

4.93

210

0.7734

100

668

3.71

270

0.5601

10

652

4.56

200

0.2421

100

652

3.20

270

0.66

50

630

3.92

222

0.2777

250

630

2.84

275

1
2

3

4

5

Table S8. The fixed wavelength of all compounds (1-5)
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MeOH
Extract
(135g)

Hexan Ext.
(66.6g)

Acetonitrile
Ext. (21.2g)

Fraction (9)
(1.308g)

Compound
4
3.5 mg

Compound
5
2.6 mg

Compound
6
1.1 mg

Butanol
Ext.
(13.88g)

Ethy
Acetate Ext.
(3.32g)

Second Hexan
Ext.

Fraction (8)
(1.07g)

Fraction (6)
(1.19g)

F (8F1)

Fract (48)
(198.7mg)

Compound
3
(5.5mg)

Compound
1
19.1 mg

Compound
2
6.2 mg

Figure S53. The isolation Scheme of compound 1-5.
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Water Ext.
(30.92)

Figure S54. The HPLC-DAD profile for Euphorbia saudiarabica crude extract.

Figure S55. The HPLC-DAD profile for n-hexanes extract
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Figure S56. The HPLC-DAD profile for Ethyl Acetate extract

Figure S57. The HPLC-DAD profile for Butanol extract
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Figure S58. The HPLC-DAD profile for Acetonitrile extract

Figure S59. The HPLC-DAD profile for Water extract
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Figure S60. The HPLC-DAD profile for Pure compound 1

Figure S61. The HPLC-DAD profile for Pure compound 2
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Figure S62. The HP-DAD profile for Pure compound 3

Figure S63. The HPLC-DAD profile for Pure compound 4
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Figure S64. The HPLC-DAD profile for Pure compound 5
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Figure S65. The UV-vis spectrum for compound 1
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Figure S66. The UV-vis spectrum for compound 2
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Figure S67. The UV-vis spectrum for compound 3
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Figure S68. The UV-vis spectrum for compound 4
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Figure S69. The UV-vis spectrum for compound 5
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Figure S70. The CD spectrum for compound 2
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Figure S71. The CD spectrum for compound 4
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Figure S72. The CD spectrum for compound 5
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600

Figure S73. 1H NMR (500 and 125 MHz, CD3OD) spectra of 6
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Figure S74. 13C NMR (500 and 125 MHz, CD3OD) spectra of 6
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Figure S75. 1H-1H COSY (500 and 125 MHz, CD3OD) spectra of 6
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Figure S76. HSQC (500 and 125 MHz, CD3OD) spectra of 6
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Figure S77. HMBC (500 and 125 MHz, CD3OD) spectra of 6
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Figure S78. NOESY (500 and 125 MHz, CD3OD) spectra of 6
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Figure S79. HRESI (+) MS spectra of 6
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